This inventor holds 1 USPTO granted patent. Top assignee: Curium US LLC. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Innovations by James Richard Spieker, Jr.
Introduction
James Richard Spieker, Jr. is an accomplished inventor based in O'Fallon, MO (US). He has made significant contributions to the field of sterility testing, particularly in the context of radionuclide generator column assemblies. His innovative approach has led to the development of a patented method that enhances the safety and efficacy of medical applications involving radionuclides.
Latest Patents
James holds a patent for "Systems and methods for sterility testing of radionuclide generator column assemblies." This method involves sterilizing a column assembly that contains a parent radionuclide. The process includes transferring the column assembly through various clean room environments and collecting sterility test samples to ensure the safety of the radionuclide used in medical treatments.
Career Highlights
James is currently employed at Curium US LLC, a company that specializes in the development and production of radiopharmaceuticals. His work at Curium has allowed him to apply his expertise in sterility testing, contributing to advancements in the field of nuclear medicine. His dedication to innovation has positioned him as a valuable asset to his team and the industry.
Collaborations
James has collaborated with notable colleagues, including Sumit Verma and Kevin Bartlett Graves. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and the development of cutting-edge solutions in the field of radionuclide applications.
Conclusion
James Richard Spieker, Jr. exemplifies the spirit of innovation in the medical field through his patented methods for sterility testing. His contributions at Curium US LLC and collaborations with fellow professionals highlight his commitment to enhancing safety in medical applications involving radionuclides.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
